US · Healthcare

Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)

Drug Manufacturers - General

Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for RICFY

P/E ratio
18.00

Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) — FAQ

What is RICFY's P/E ratio?

The price-to-earnings (P/E) ratio for Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) is 18.00 (data as of 2026-05-23).

Does Recordati Industria Chimica e Farmaceutica S.p.A. pay a dividend?

Dividend yield is not available in the current snapshot for Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY). Check the MyAverix Finance app for the latest dividend data.

What sector is Recordati Industria Chimica e Farmaceutica S.p.A. in?

Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is RICFY listed on?

RICFY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play